CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
High ImpactOriginal article

Withdrawn | Cancer Accelerated Approvals

RegulatoryrejectedNegative
AI Analysis

Summary

Accelerated approval(s) for malignant hematology and oncology indications have been withdrawn and are no longer FDA-approved.

Outcome Details

Accelerated approval withdrawn

Importance:8/10
Sentiment:
-1.00
regulatoryaccelerated_approvalwithdrawaloncologyhematology
Related Companies

Read the original article

Published by FDA Drugs (New Approvals & NDA) on October 5, 2026 9:49 AM

Read Original